Thread: Pirenzepine
View Single Post
Old 08-02-2019, 06:47 AM
Happytobehere Happytobehere is offline
Junior Member
 
Join Date: Jun 2019
Posts: 9
3 yr Member
Happytobehere Happytobehere is offline
Junior Member
 
Join Date: Jun 2019
Posts: 9
3 yr Member
Default

Quote:
Originally Posted by mhw69 View Post
You are correct that anticholernergic drugs have been associated with an increased risk of dementia. I believe though that people need to weigh the risk of dementia against the very rule and pervasive problems that someone with small fiber neuropathy potentially faces. Obviously, there is pain and sensory issues which can be harsh but there is also the very real danger of autonomic neuropathy.

Many people with small fiber neuropathy experience some level of autonomic neuropathy. These range from cardiovascular complaints ( palpitations / arrhythmias, POTS, more generalized higher beat, exercise intolerance, etc.) to gastrointestinal issues ( constipation, diarrhea, gastroparesis, GERD, etc.), to other more miscellaneous issues ( sweating problems, other organ issues). Let me be clear: autonomic neuropathy can kill you. Cardiac Autonomic Neuropathy kills people all the time. Whenever you hear people dying from "complications of diabetes", one of the big ones is cardiac autonomic neuropathy triggering an episode of sudden cardiac death. As for Enteric Neuropathy ( GI neuropathy), constipation and diarrhea are a pain but gastroparesis can really negatively impact health.

If the M1R antagonists ( pirenzepine, oxybutynin, etc.) can trigger small fiber nerve regeneration, regrowing these nerves would have the potential of halting the progression of the neuropathy and reversing these symptoms. On balance, I would take halting the progression and/or reversing the sensory and autonomic neuropathic symptoms of this disease for an increased risk of dementia. In addition, if you get to a good place with your neuropathy, there is no indication that you would need to keep the dosage the same which might ameliorate somewhat the risk of developing dementia. Just my two cents.
Thank you so much for your sensible reply. I had also heard of the dementia risk and I'm more than willing to take the risk because it also might no cause dementia so again thanks for your sensible reply. A doctor had prescribed oxybutynin 5mg oral dosage but at a little over 4 weeks my feet began to swell, I quit for a few days and my swelled feet went down I then tried 1/2 of the 5mg pill but again after a few more weeks my feet again swelled badly. I think trans dermal is suppose to side step some of the swelling while applying the medicine directly to the effected nerves for better repair of the nerves but I would need a trans dermal gel for that. That's why I was asking about trans dermal delivery. Does anyone think trans dermal will sidestep the swelling feet problem? Also I've found an online supplier for pirenzepine but Its hard to trust foreign pharmaceutical suppliers. I'm not so much afraid of the medicine not being the correct medicine as much as I am afraid of them simply taking the money and just not sending anything therefore costing more time in getting relief and I read some where that the closer to the onset of the neuropathy the medicine is applied the better the chances the medicine will work, I don't know if this is true or not. perhaps others here may know more about this. I have used aldaychemist (an india based company) with great success for other needs but they don't carry pirenzepine. It would be of great help if anyone knows of a legit foreign supplier of pirenzepine. Its not on any US banned list or anything so it shouldn't be a problem. And I might mention that towards the end of the 6 to 7 weeks total I used the oxybutynin my fingers started getting a very slight electrical sensation to touch where before there was no sensation at all so I know this stuff does do something. Sorry for the long post but thanks again for an encouraging reply and also thanks for your and everyone else's time in reading this.
Happytobehere is offline   Reply With QuoteReply With Quote